Member Info for Indie07

....

In the RNS So many shorters jumped in board early morning trying to spin the RNS into negativity and beyond... good luck with that... the. Came the flurry of shorts closing midday ish ... hmmm.. “Graham Lumsden, Chief Executive Officer of Motif Bio, said: "We are pleased that the FDA has granted our meeting request and that critical personnel from the FDA have been invited to attend the upcoming meeting with our internal and external experts. We look forward to a collaborative meeting and to discussing with the Agency the best way to move iclaprim towards marketing approval."

Type A meetings, which are used to help "an otherwise stalled product development program proceed." Type B meetings, which are routine meetings occurring at pre-defined endpoints between FDA and a sponsor. Meetings typically occur right after or right before the submission of clinical data or a new drug filing.

Or capital raise, which would be a good rns Imho

Maybe not the pressure for buying is still intense

Then maybe another ride into the Close

Earlier today

On my screen

Through the rafters

?

Live

Month ago

!

Going nuts

...

Now that uncertainty is out if the way Unlikely be able to top up tho!

Not a trading stock though Medium term hold for rewards

Steady climb to 6p imho Dyor 15p last June Director buys Read all the gumpf

Director buying

:)